Medical News and Perspectives |

AIDS Drug Programs Tighten Belts Even as Medications Are Shown to Curb Contagion

Richard Trubo
JAMA. 2011;306(3):253-255. doi:10.1001/jama.2011.979.
Text Size: A A A
Published online


The troubled economy is creating funding shortfalls for AIDS Drug Assistance Programs (ADAPs), even as financial difficulties increase the need for help among some of the low-income HIV/AIDS patients who rely on these programs to supply their medication.

Meanwhile, the need for such programs continues to intensify in the wake of a recent large-scale international study that demonstrated the effectiveness of oral antiretroviral drugs in safeguarding the uninfected sexual partners of individuals with HIV infection. The trial showed protective benefits when these drugs were taken by HIV-positive persons with an immune system that was still relatively uncompromised (the immediate-treatment group). Data from this randomized controlled trial from the HIV Prevention Trials Network (HPTN) were released in May, earlier than the scheduled 2015 completion date for the study, because of the markedly positive results. The ongoing trial (HPTN 052) is now being modified to offer antiretroviral therapy to all HIV-infected study participants in the deferred-treatment group, according to Myron S. Cohen, MD, chair of the study and director of the Institute for Global Health and Infectious Diseases at the University of North Carolina at Chapel Hill.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Waiting lists for AIDS Drug Assistance Programs, which supply medication to low-income individuals with HIV, have grown because of funding shortfalls related to the troubled economy.



Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles